Abstract:OBJECTIVE:To design, construct and select the optimal replication-defective recombinant adenovirus mediated short hairpin RNA (shRNA) which is transduced into human osteosarcoma cells to silence c-myc gene expression, and to construct the recombinant adenovirus vector expressing c-myc-shRNA and determine its viral titer.METHODS:Three pairs of complementary single-stranded oligonucleotides (ss oligos) were designed and synthesized, and then they were annealed to create a double-stranded oligonucleotide (ds oligos).The ds oligos were cloned into pENTR/U6 vector to produce the shuttle plasmid pENTR/U6-shRNA, which was transduced into osteosarcoma cells by liposome after sequencing. The plasmid with good silence effect was chosen by RT-PCR to perform the LR recombination reaction to the adenovirus backbone plasmid. The expression clone was transfected into HEK293A cells to produce replication-incompetent recombinant adenovirus mediated shRNA against c-myc whose cytopathic effect was observed and viral titer was determined by the viral particle (VP) method and 50% tissue culture infective dose (TCID50).RESULTS:Ds oligos, which was verified by electrophoresis, was cloned into pENTR/U6 vector to produce pENTR/U6-shRNA shuttle plasmid, which was confirmed to be corrected by sequencing. The optimal plasmid with good silence effect was chosen by RT-PCR from the three pairs of double-stranded oligonucleotide. By Pac I enzyme, the linearization replication-defective recombinant adenovirus mediated shRNA was constructed to perform the LR recombination reaction to the adenovirus backbone plasmid. The cytopathic effect and vacuole phenomenon of adenovirus mediated shRNA appeared at 3 days and became obvious at 6 days. The adenovirus virus titer in the first generation was 5.23 x 10(9) VP/mL, and reached 2.26 x 10(12) VP/mL via 3-4 generations' amplification. The viral titer was 10(-3.8)/0.1 mL determined by VP method and TCID50.CONCLUSION:The recombinant adenovirus mediated shRNA c-myc is constructed in vitro through RNA interference technology.

Construction, Screening and Evaluation of a Derivative Recombinant Adenovirus for the Optimal Sirna Targeting of a Novel Gene (HA117).

Inhibition Of Sars-Cov Gene Expression By Adenovirus-Delivered Small Hairpin Rna

Obtaining of high titer recombined adenovirus carring HA117 gene and its expression in K562 cells

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

[Construction of the Recombinant Adenovirus Vector Bearing Dual-Survivin Shrna].

Multidrug resistant function of adenovirus vector mediated novel gene HA117 in Jurkat cells

HA117 Gene Increased the Multidrug Resistance of K562 Cells in Vitro: an Investigation to the Function of a Novel Gene Related to Drug Resistance

Homologous Recombination-Based Adenovirus Vector System for Tumor Cell-Specific Gene Delivery

Construction of an Adenovirus Vector Encoding Mutant K-ras siRNA and Its Effect on the H441 Human Lung Cancer Cell Line

Construction and Biological Evaluation of a Novel Integrin Ανβ3-Specific Carrier for Targeted Sirna Delivery in Vitro

Recombinant adenovirus and application thereof

Construction of retargeting helper adenovirus and its functions

Construction of Adeno-associated Virus RNA Interference System to Target E2F3 Gene

Construction and Purification of the Recombinant Adenoviral Vector Carrying Antisense RNA to Chemokine Receptor CCR5

Construction and Identification of GGPPS Gene Interference Adenovirus

Construction and identification of the recombinant adenovirus vector carrying a small interfering RNA targeting the peroxisome proliferator-activated receptor-γ

Construction and Identification of Adenovirus Vector Site-Specific for Antisense B7-H1 Gene

Construction and identification of recombinant adenovirus expressing the hemagglutinin gene of H5N1 subtype avian influenza virus

CONSTRUCTION OF RECOMBINANT ADENOVIRUS VECTOR BY C-MYC SILENCING

Construction and Identification of cnksr2 Gene Interference Adenovirus

Construction of Replication-defective Recombinant Adenoviruses Expressing Influenza Virus Hemagglutinin and Study on Its Immune Responses